Response to Ma et al
- PMID: 38283391
- PMCID: PMC10812836
- DOI: 10.14309/ajg.0000000000002543
Response to Ma et al
Conflict of interest statement
Dr. Ludvigsson coordinates a study on behalf of the Swedish IBD quality register (SWIBREG). That study has received funding from the Janssen corporation. Dr Ludvigsson has also received financial support from MSD to develop a paper reviewing national healthcare registers in China.
Comment on
-
Acute Pancreatitis After Microscopic Colitis: Is It due to Drugs or Disease?Am J Gastroenterol. 2024 Jan 1;119(1):215-216. doi: 10.14309/ajg.0000000000002388. Am J Gastroenterol. 2024. PMID: 38174916 No abstract available.
References
-
- Ma T, Han D, Sun M. Acute Pancreatitis after Microscopic Colitis: Is it Due to Drugs or Disease? Am J Gastroenterol 2023: This issue. - PubMed
-
- Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648–61; quiz - PubMed
-
- Lesnovska KP, Munch A, Bonderup O, Magro F, Kupcinskas J, Zabana Y, et al. The Process of Developing a Disease Activity Index in Microscopic Colitis. J Crohns Colitis. 2022;16(3):452–9. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
